Microbes and Cancer: Friends or Faux?

被引:66
作者
Azevedo, Maria Manuel [1 ,2 ,3 ]
Pina-Vaz, Cidalia [1 ,2 ]
Baltazar, Fatima [4 ,5 ,6 ]
机构
[1] Univ Porto, Fac Med, Dept Microbiol, P-4200319 Porto, Portugal
[2] Univ Porto, Fac Med, CINTESIS, P-4200319 Porto, Portugal
[3] Agrp Escolas D Maria II, P-4760067 V N Famalicao, Portugal
[4] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal
[5] ICVS 3Bs PT Govt Associate Lab, P-4710057 Braga, Portugal
[6] ICVS 3Bs PT Govt Associate Lab, P-4835258 Guimaraes, Portugal
关键词
cancer; infection; microbiome; cancer dysbiosis; tumor microbiome; cancer therapy response; EPSTEIN-BARR-VIRUS; INVASIVE FUNGAL-INFECTIONS; NON-HODGKINS-LYMPHOMA; PANCREATIC-CANCER; HELICOBACTER-PYLORI; GUT MICROBIOTA; GASTRIC-CANCER; TRANSPLANT RECIPIENTS; COLORECTAL-CANCER; CURRENT KNOWLEDGE;
D O I
10.3390/ijms21093115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is one of the most aggressive and deadly diseases in the world, representing the second leading cause of death. It is a multifactorial disease, in which genetic alterations play a key role, but several environmental factors also contribute to its development and progression. Infections induced by certain viruses, bacteria, fungi and parasites constitute risk factors for cancer, being chronic infection associated to the development of certain types of cancer. On the other hand, susceptibility to infectious diseases is higher in cancer patients. The state of the host immune system plays a crucial role in the susceptibility to both infection and cancer. Importantly, immunosuppressive cancer treatments increase the risk of infection, by decreasing the host defenses. Furthermore, alterations in the host microbiota is also a key factor in the susceptibility to develop cancer. More recently, the identification of a tumor microbiota, in which bacteria establish a symbiotic relationship with cancer cells, opened a new area of research. There is evidence demonstrating that the interaction between bacteria and cancer cells can modulate the anticancer drug response and toxicity. The present review focuses on the interaction between microbes and cancer, specifically aiming to: (1) review the main infectious agents associated with development of cancer and the role of microbiota in cancer susceptibility; (2) highlight the higher vulnerability of cancer patients to acquire infectious diseases; (3) document the relationship between cancer cells and tissue microbiota; (4) describe the role of intratumoral bacteria in the response and toxicity to cancer therapy.
引用
收藏
页数:23
相关论文
共 189 条
  • [11] Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer
    Arthur, Janelle C.
    Gharaibeh, Raad Z.
    Muehlbauer, Marcus
    Perez-Chanona, Ernesto
    Uronis, Joshua M.
    McCafferty, Jonathan
    Fodor, Anthony A.
    Jobin, Christian
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [12] Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan
    Asaka, Masahiro
    Kato, Mototsugu
    Sakamoto, Naoya
    [J]. JOURNAL OF GASTROENTEROLOGY, 2014, 49 (01) : 1 - 8
  • [13] Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection
    Asiaf, Asia
    Ahmad, Shiekh T.
    Mohammad, Sheikh O.
    Zargar, Mohammad A.
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2014, 23 (03) : 206 - 224
  • [14] Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
    Auberger, Jutta
    Lass-Floerl, Cornelia
    Ulmer, Hanno
    Nogler-Semenitz, Elisabeth
    Clausen, Johannes
    Gunsilius, Eberhard
    Einsele, Hermann
    Gastl, Guenther
    Nachbaur, David
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (05) : 508 - 515
  • [15] Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer
    Aviles-Jimenez, Francisco
    Vazquez-Jimenez, Flor
    Medrano-Guzman, Rafael
    Mantilla, Alejandra
    Torres, Javier
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [16] EBV persistence in memory B cells in vivo
    Babcock, GJ
    Decker, LL
    Volk, M
    Thorley-Lawson, DA
    [J]. IMMUNITY, 1998, 9 (03) : 395 - 404
  • [17] Beatrous Surget V, 2017, Dermatol Online J, V23
  • [18] Epidemiology of candidemia in patients with hematologic malignancies and solid tumours in Brazil
    Bergamasco, M. D.
    Garnica, M.
    Colombo, A. L.
    Nucci, M.
    [J]. MYCOSES, 2013, 56 (03) : 256 - 263
  • [19] RISK OF OTHER CANCERS FOLLOWING KAPOSIS-SARCOMA - RELATION TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BIGGAR, RJ
    CURTIS, RE
    COTE, TR
    RABKIN, CS
    MELBYE, M
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (04) : 362 - 368
  • [20] Molecular analysis of the bacterial microbiota in the human stomach
    Bik, EM
    Eckburg, PB
    Gill, SR
    Nelson, KE
    Purdom, EA
    Francois, F
    Perez-Perez, G
    Blaser, MJ
    Relman, DA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (03) : 732 - 737